Abstract: A compression garment, for example a pair of compression shorts (10, 210, 310), has a trunk section (20), a left leg section (30) and a right leg section (40) constructed from a resilient material. The trunk section (20) is reinforced such that a wearer's pelvic region is subjected to a first compressive force acting diagonally across a front portion of the trunk section from left to right and a second compressive force acting diagonally from right to left. The range of motion at the wearer's hips is preferably not restricted by the reinforcement.

Abstract: The present invention discloses a stand for a cooler containing cooling solution. The cooler further includes an attached flexible tubing outlet for draining the cooling solution through the flexible tube outlet into a medical cuff for reducing swelling of injured tissue. The stand further comprises a cylindrical container with a cavity for receiving through the opened top end of the lateral sidewall the cooler therein. An elongated pedestal is further defined by a top end and a bottom end. The top end of the pedestal is attached underneath the bottom side of the container. The container is supported in an upright position a distance above the surface of the ground. An aperture is located in the lateral side wall for receiving the flexible tubing outlet therethrough.

Abstract: A catalyst precursor for preparing a catalyst suitable for use in a sour water-gas shift process is described, including; 5 to 30% by weight of a catalytically active metal oxide selected from tungsten oxide and molybdenum oxide; 1 to 10% by weight of a promoter metal oxide selected from cobalt oxide and nickel oxide; and 1 to 15% by weight of an oxide of an alkali metal selected from sodium, potassium and caesium; supported on a titania catalyst support.

Abstract: The present invention relates to mono-specific and multi-specific polypeptide therapeutics that specifically target cells expressing prostate-specific membrane antigen (PSMA) and are useful for the treatment of prostate cancer (e.g., castrate-resistant prostate cancer), tumor-related angiogenesis or benign prostatic hyperplasia (BPH). In one embodiment, the multi-specific polypeptide therapeutics bind both PSMA-expressing cells and the T-cell receptor complex on T cells to induce target-dependent T-cell cytotoxicity, activation and proliferation.

Abstract: A catheter lock composition for preventing bacterial infection having an effective amount of glycerol and sodium chloride solution. The effective amount of glycerol is between about 35-60% and sodium chloride is in a concentration range between 0.5-0.9%. The composition further includes an anticoagulant and/or an antimicrobial agent.

Abstract: An electricity storage system comprising a reversible fuel cell having a first electrode and a second electrode separated by an ionically conducting electrolyte, and at least two chambers adapted to hold fuel and/or a reaction product, wherein the system is substantially closed and at least one reactant for discharge is hydrogen or oxygen.

Abstract: A multi-state viewing mode user interface (UI) element is used to switch between different viewing modes on a display of a computing device. A user may switch between hidden mode where commands are hidden, a collapsed mode where a portion of the commands are hidden, and an expanded mode where the commands are shown on the display. The viewing mode UI element may remain displayed such that a user may interact with the element to switch to another viewing mode. A trigger zone UI element may be displayed that when activated temporarily displays commands that are hidden according to the selected viewing mode. Other UI elements (e.g. closing the application) may also be shown. A selected viewing mode may persist across an application closing and re-opening. A status UI element may also be surfaced (e.g. temporarily) to indicate various events.

Abstract: Effective devices and methods using a chemonucleolysis agent are provided for treating an intervertebral disc or treating spinal arachnoiditis. The devices and methods comprise a chemonucleolysis agent to degrade or to shrink at least a portion of the intervertebral disc. In some embodiments, the methods and devices are configured to immediately release an effective amount of the chemonucleolysis agent within 24 hours and provide sustained release of the chemonucleolysis agent over a period of up to one year to treat the intervertebral disc. In some embodiments, the chemonucleolysis agent in the device is administered in or near the intrathecal space and/or thecal sac to treat spinal arachnoiditis.

Abstract: A deblocking filter module can be used in a video processing device that processes a video input signal in accordance with a plurality of coding parameters. The deblocking filter module includes an adaptive deblocking filter that receives a plurality of samples and produces a plurality of filtered samples in response thereto, the adaptive deblocking filter having at least one filter parameter that is controllable in response to a filter control signal. A filter control module generates the filter control signal based on the plurality of coding parameters.

Abstract: The present invention relates to the construction of a new class of Targeted Secretion Inhibitors (TSIs), which comprise a non-cytotoxic protease, translocation peptide and a targeting moiety peptide, wherein the targeting moiety peptide has a free N-terminal domain and a free C-terminal domain; to a single-chain fusion protein precursor thereof, and to a method of activating said single-chain fusion protein precursor.

Abstract: This invention provides methods and kits for diagnosing, ascertaining the clinical course of minimal residual disease associated with acute lymphoblastic leukemia (ALL). Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with diseases associated with ALL based on patterns of surface marker expression unique to ALL.

Abstract: A medical device including a shaft having an elongated inner member and an elongated tubular reinforcing member disposed over at least a portion of the inner member. In some embodiments, at least a portion of the outer surface of the inner member is spaced from the inner surface of the reinforcing member, defining a space substantially free of any other structures of the device. In some embodiments, the shaft can include a tip structure disposed on a distal portion of the inner member. In some such embodiments, the reinforcing member has a distal end, and the tip structure is disposed on the distal portion of the inner member adjacent the distal end of the reinforcing member. Additionally, in some embodiments, the reinforcing member can include a plurality of apertures defined therein, for example, to enhance the flexibility or other such characteristics of all or portions of the reinforcing member.

Abstract: A method and system for discriminating ventricular arrhythmia is disclosed. In an embodiment, the method can include implementing an arrhythmia discrimination algorithm that can discriminate between supraventricular tachycardia (SVT) and ventricular tachycardia (VT) using at least one programmable parameter programmed to a first value. The method can include analyzing an SVT event, where analyzing the SVT event can include sensing a physiological signal during the SVT event and identifying characteristics of the sensed physiological signal. The method can further include analyzing a cardiac signal to classify the cardiac signal as either an SVT or a VT using the arrhythmia discrimination algorithm with the programmable parameter (programmed to a second value. The second value can be determined from the identified characteristics of the sensed physiological signal.

Abstract: The invention concerns benzamide compounds of formula (I): compound of formula (I): wherein R1 is a C-linked pyrazole ring, which is optionally substituted by one or more groups selected from C1-4alkyl, C3-4cycloalkyl, C1-4alkoxy and C3-4cycloalkoxy; or a pharmaceutically acceptable salt or pro-drug form thereof. The invention also concerns processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumors or other proliferative conditions, which are sensitive to the inhibition of histone deacetylase (HDAC).

Abstract: The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.

Abstract: The present invention is a method of making a composite polymeric material by dissolving a vinyl thermoplastic polymer, un-functionalized carbon nanotubes and hydroxylated carbon nanotubes and optionally additives in a solvent to make a solution and removing at least a portion of the solvent after casting onto a substrate to make thin films. The material has enhanced conductivity properties due to the blending of the un-functionalized and hydroxylated carbon nanotubes.

Abstract: A surface treatment robot includes a chassis having forward and rear ends and a drive system carried by the chassis. The drive system includes right and left driven wheels and is configured to maneuver the robot over a cleaning surface. The robot includes a vacuum assembly, a collection volume, a supply volume, an applicator, and a wetting element, each carried by the chassis. The wetting element engages the cleaning surface to distribute a cleaning liquid applied to the surface by the applicator. The wetting element distributes the cleaning liquid along at least a portion of the cleaning surface when the robot is driven in a forward direction. The wetting element is arranged substantially forward of a transverse axis defined by the right and left driven wheels, and the wetting element slidably supports at least about ten percent of the mass of the robot above the cleaning surface.

Abstract: Methods, image processors and imaging devices for capturing a high dynamic range (HDR) image. Multiple images of a scene are captured at respectively different exposure settings. A further image of an object placed in the scene is captured at one exposure setting. A first radiance image is formed from the multiple images. A second radiance image is formed from the further image. The first radiance image and the second radiance image are merged to form the HDR image.

Abstract: Apparatus and method of forming and displaying high dynamic range (HDR) images for various purposes including the testing of image capture devices, such as cameras. A display device has a display panel carrying a plurality of rendered images formed from image data of a scene. At least one light source is used to illuminate the rendered images on the display panel. When the rendered images are aligned with one another and illuminated by the light source, the rendered images are capable of forming a display image having a dynamic range higher than those of the rendered images.

Abstract: Compositions and methods for preventing and treating pneumococcal infections are provided. Compositions include novel polypeptides comprising an amino acid sequence corresponding to the R2i or R22 domain of CbpA or a consensus sequence of one of these domains, and variants and fragments thereof, wherein the polypeptide is stabilized in a desired conformation, particularly a loop conformation. The polypeptides of the invention may be engineered to comprise a first and a second cysteine residue, thereby resulting in the formation of a disulfide bond that stabilizes the polypeptide in the desired conformation. Alternatively, a polypeptide of the invention may be modified to create a synthetic linkage between a first and second amino acid residue present within the polypeptide, wherein the synthetic linkage stabilizes the polypeptide in the desired conformation. The polypeptides of the invention may further comprise an amino acid sequence for a T cell epitope.